EGFR Monoclonal Antibodies in the Treatment of Squamous Cell Carcinoma of the Head and Neck: A View beyond Cetuximab

Squamous cell carcinoma of the head and neck (SCCHN) is a prevalent disease both in the United States and worldwide with an overall poor prognosis, in part due to limited activity of existing therapy. Primary therapy is largely dictated by the anatomical origin of the cancer and whether distant dise...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kono, Scott A., Haigentz, Missak, Yom, Sue S., Saba, Nabil
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3465896/
https://ncbi.nlm.nih.gov/pubmed/23056941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/901320
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares